Comparison between Concord Biotech IPO and Pyramid Technoplast IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Pyramid Technoplast IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the Pyramid Technoplast IPO is up to ₹153.05 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Pyramid Technoplast IPO is ₹166.00 per share.
| Concord Biotech IPO | Pyramid Technoplast IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹151.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹166.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹166.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | |
| Market Lot Size | 20 shares | 90 shares |
| Fresh Issue Size | 0 shares | 55,00,000 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹91.30 Cr |
| OFS Issue Size | 2,09,25,652 shares | 37,20,000 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹61.75 Cr |
| Issue Size Total | 2,09,25,652 shares | 92,20,000 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹153.05 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Pyramid Technoplast IPO opens on Aug 18, 2023. The closing date of Concord Biotech IPO and Pyramid Technoplast IPO is Aug 08, 2023, and Aug 22, 2023, respectively.
| Concord Biotech IPO | Pyramid Technoplast IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Aug 17, 2023 |
| Issue Open | Aug 04, 2023 | Aug 18, 2023 |
| Issue Close | Aug 08, 2023 | Aug 22, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 25, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Aug 28, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Aug 29, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Aug 29, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Sep 24, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Nov 23, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Pyramid Technoplast IPO P/E ratio of 16.21.
| Concord Biotech IPO | Pyramid Technoplast IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 100.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 74.94 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 16.21 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹611.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 29.61% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | 21.37% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹10.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 29.61% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in Pyramid Technoplast IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 11,06,400 shares in Pyramid Technoplast IPO.
| Concord Biotech IPO | Pyramid Technoplast IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 16,59,600 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 11,06,400 shares |
| NII | 31,37,348 shares | 18,44,000 shares |
| RII | 73,20,479 shares | 46,10,000 shares |
| Employee | 10,000 shares | |
| Others | ||
| Total | 2,09,25,652 shares | 92,20,000 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Pyramid Technoplast IPO subscribed 18.29x.
| Concord Biotech IPO | Pyramid Technoplast IPO | |
|---|---|---|
| QIB (times) | 67.67x | 9.94x |
| NII (times) | 16.99x | 32.24x |
| Big NII (times) | 19.30x | 33.81x |
| Small NII (times) | 12.37x | 29.09x |
| RII (times) | 3.78x | 14.72x |
| Employee (times) | 24.48x | |
| Other (times) | ||
| Total (times) | 24.87x | 18.29x |
